Impact BioMedical Inc. (IBO) Earnings History
Annual and quarterly earnings data from 2017 to 2024
Loading earnings history...
IBO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
IBO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 100.0% | 23.7% | -88.0% |
| 2023 | - | - | - |
| 2022 | 100.0% | -6808.0% | -14102.0% |
| 2021 | 100.0% | -6808.0% | -14102.0% |
| 2020 | - | - | - |
Download Data
Export IBO earnings history in CSV or JSON format
Free sign-in required to download data
Impact BioMedical Inc. (IBO) Earnings Overview
As of May 8, 2026, Impact BioMedical Inc. (IBO) reported trailing twelve-month net income of -$25M, reflecting +0.0% year-over-year growth. The company earned $-2.07 per diluted share over the past four quarters, with a net profit margin of -88.0%.
Looking at the long-term picture, IBO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$98,109 in fiscal 2018.
Impact BioMedical Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NNVC (-$2.22T net income), NVAX (-$88M net income, 39.2% margin), VXRT ($16M net income, 6.9% margin), IBO has comparable earnings metrics. Compare IBO vs NNVC →
IBO Earnings vs Peers
Earnings metrics vs comparable public companies
IBO Historical Earnings Data (2017–2024)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$2M | +52.7% | $551,664 | $-0.01 | -88.0% | 23.7% |
| 2023 | -$4M | +38.5% | -$4M | $-0.01 | - | - |
| 2022 | -$7M | +0.0% | -$3M | $-0.61 | -14102.0% | -6808.0% |
| 2021 | -$7M | -827.7% | -$3M | $-0.61 | -14102.0% | -6808.0% |
| 2020 | $-760,069 | -28.8% | -$1M | $-0.01 | - | - |
| 2019 | $-590,080 | -501.5% | $-680,025 | $-0.01 | - | - |
| 2018 | $-98,109 | +76.0% | $-33,861 | $-0.01 | - | - |
| 2017 | $-408,289 | - | $63,952 | $-0.04 | - | - |
See IBO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IBO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IBO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIBO — Frequently Asked Questions
Quick answers to the most common questions about buying IBO stock.
Is IBO growing earnings?
IBO TTM EPS: $-2.07. Net income: $-25M. Earnings growth: +0.0%.
What are IBO's profit margins?
Impact BioMedical Inc. net margin is -88.0%, with operating margin at +23.7%. Below-average margins reflect competitive or cost pressures.
How consistent are IBO's earnings?
IBO earnings data spans 2017-2024. The current earnings trend is +0.0% YoY. Historical data enables comparison across business cycles.